Johnson & Johnson (BKK:JNJ03)

Thailand flag Thailand · Delayed Price · Currency is THB
3.740
-0.020 (-0.53%)
Last updated: Feb 10, 2026, 3:09 PM ICT
Market Cap17.89T +50.8%
Revenue (ttm)2.92T +6.0%
Net Income831.33B +90.6%
EPS342.10 +90.5%
Shares Outn/a
PE Ratio21.52
Forward PE20.47
Dividend0.02 (0.44%)
Ex-Dividend DateNov 25, 2025
Volume15,654
Average Volume196,107
Open3.720
Previous Close3.760
Day's Range3.720 - 3.740
52-Week Range2.980 - 3.860
Betan/a
RSI75.26
Earnings DateJan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange Stock Exchange of Thailand
Ticker Symbol JNJ03
Full Company Profile

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD Financial Statements